New Malaria Interventions Lead to Fewer Deaths

A recent report from Kenya’s Ministry of Health confirms a dramatic drop in malaria-related deaths, citing a 93% decline over the past decade. Health officials credit this success to a combination of strengthened vector control measures, improved diagnostic systems, and community-led interventions under the Kenya Malaria Strategy 2023–2027.
One of the most promising developments is the adoption of ivermectin as part of the malaria control toolkit. A landmark study by KEMRI in July 2025 revealed that when ivermectin is distributed through mass drug administration (MDA), malaria infections dropped by 26% in areas with high coverage — demonstrating its value as a complementary tool where conventional strategies are losing effectiveness.
The rollout of the RTS,S malaria vaccine has also contributed significantly to reducing severe cases and deaths, especially among children. According to WHO, Kenya has expanded its vaccine program to cover more sub-counties, helping buffer the most vulnerable children against fatal malaria attacks.
Still, experts warn that progress could be reversed if investments falter. Key partners, including the End Malaria Council and KEMRI, are calling for continued domestic and international funding to scale up interventions, strengthen resistance surveillance, and maintain high coverage of prevention tools.